Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In patients with metabolic-associated steatotic liver disease or metabolic-associated ...
SAN ANTONIO, Nov. 25, 2025 – From metabolic villain to hero? The hormone glucagon that raises blood sugar is now getting a second look to see how it actually contributes to insulin secretion, glucose ...
Severe hypoglycemia (low blood sugar) can cause people with diabetes to have seizures or lose consciousness, which can make it impossible to treat low blood sugar by eating or drinking something ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — A weekly glucagon/GLP-1 dual receptor ...
Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss. Objective: Obesity affects more than 40 ...
People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which ...
New findings raise the possibility of promising therapeutic strategies for the management of hypoglycemia in type 1 diabetes patients. Study: Loss of electrical β-cell to δ-cell coupling underlies ...
Effects of HPV vaccination on the development of HPV-related cancers: A retrospective analysis of a United States-based cohort. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results